These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30638931)

  • 21. Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations.
    Soblet J; Kangas J; Nätynki M; Mendola A; Helaers R; Uebelhoer M; Kaakinen M; Cordisco M; Dompmartin A; Enjolras O; Holden S; Irvine AD; Kangesu L; Léauté-Labrèze C; Lanoel A; Lokmic Z; Maas S; McAleer MA; Penington A; Rieu P; Syed S; van der Vleuten C; Watson R; Fishman SJ; Mulliken JB; Eklund L; Limaye N; Boon LM; Vikkula M
    J Invest Dermatol; 2017 Jan; 137(1):207-216. PubMed ID: 27519652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic Activating PIK3CA Mutations Cause Venous Malformation.
    Limaye N; Kangas J; Mendola A; Godfraind C; Schlögel MJ; Helaers R; Eklund L; Boon LM; Vikkula M
    Am J Hum Genet; 2015 Dec; 97(6):914-21. PubMed ID: 26637981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.
    Vikkula M; Boon LM; Carraway KL; Calvert JT; Diamonti AJ; Goumnerov B; Pasyk KA; Marchuk DA; Warman ML; Cantley LC; Mulliken JB; Olsen BR
    Cell; 1996 Dec; 87(7):1181-90. PubMed ID: 8980225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD10 and CD34 as markers in vascular malformations with PIK3CA and TEK mutations.
    Moneghini L; Tosi D; Graziani D; Caretti A; Colletti G; Baraldini V; Cattaneo E; Spaccini L; Zocca A; Bulfamante GP
    Hum Pathol; 2020 May; 99():98-106. PubMed ID: 32272124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disorganized vascular structures in sporadic venous malformations: a possible correlation with balancing effect between Tie2 and TGF-β.
    Chen G; Ren JG; Zhang W; Sun YF; Wang FQ; Li RF; Zhang J; Zhao YF
    Sci Rep; 2014 Jun; 4():5457. PubMed ID: 24966004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association study between of Tie2/angiopoietin-2 and VEGF/KDR pathway gene polymorphisms and vascular malformations.
    Zheng Q; Du J; Zhang Z; Xu J; Fu L; Cao Y; Huang X; Guo L
    Gene; 2013 Jul; 523(2):195-8. PubMed ID: 23566851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
    Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
    Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response.
    Korpelainen EI; Kärkkäinen M; Gunji Y; Vikkula M; Alitalo K
    Oncogene; 1999 Jan; 18(1):1-8. PubMed ID: 9926914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shear stress activates Tie2 receptor tyrosine kinase in human endothelial cells.
    Lee HJ; Koh GY
    Biochem Biophys Res Commun; 2003 May; 304(2):399-404. PubMed ID: 12711329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Xenograft Model for Venous Malformation.
    Goines J; Boscolo E
    Methods Mol Biol; 2021; 2206():179-192. PubMed ID: 32754818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective role of a distinct tyrosine residue on Tie2 in heart development and early hematopoiesis.
    Tachibana K; Jones N; Dumont DJ; Puri MC; Bernstein A
    Mol Cell Biol; 2005 Jun; 25(11):4693-702. PubMed ID: 15899871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene control of tyrosine kinase TIE2 and vascular manifestations of infections.
    Ghosh CC; David S; Zhang R; Berghelli A; Milam K; Higgins SJ; Hunter J; Mukherjee A; Wei Y; Tran M; Suber F; Kobzik L; Kain KC; Lu S; Santel A; Yano K; Guha P; Dumont DJ; Christiani DC; Parikh SM
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):2472-7. PubMed ID: 26884170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic effects of autophosphorylation on receptor tyrosine kinase catalysis: enzymatic characterization of Tie2 and phospho-Tie2.
    Murray BW; Padrique ES; Pinko C; McTigue MA
    Biochemistry; 2001 Aug; 40(34):10243-53. PubMed ID: 11513602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Molecular Therapies for Venous Malformations.
    Kangas J; Nätynki M; Eklund L
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():6-19. PubMed ID: 29668117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shear stress-induced activation of Tie2-dependent signaling pathway enhances reendothelialization capacity of early endothelial progenitor cells.
    Yang Z; Xia WH; Zhang YY; Xu SY; Liu X; Zhang XY; Yu BB; Qiu YX; Tao J
    J Mol Cell Cardiol; 2012 May; 52(5):1155-63. PubMed ID: 22326430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calmodulin Mediates Ca2+-Dependent Inhibition of Tie2 Signaling and Acts as a Developmental Brake During Embryonic Angiogenesis.
    Yang C; Ohk J; Lee JY; Kim EJ; Kim J; Han S; Park D; Jung H; Kim C
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1406-16. PubMed ID: 27199448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular anomalies of the head and neck: a review of genetics.
    Yadav P; De Castro DK; Waner M; Meyer L; Fay A
    Semin Ophthalmol; 2013; 28(5-6):257-66. PubMed ID: 24010650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facial cutaneo-mucosal venous malformations can develop independently of mutation of TEK gene but may be associated with excessive expression of Src and p-Src.
    Brahami N; Subramaniam S; Al-Ddafari MS; Elkaim C; Harmand PO; Sari BE; Lefranc G; Aribi M
    J Negat Results Biomed; 2017 Mar; 16(1):9. PubMed ID: 28316284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A negative regulatory role for Y1111 on the Tie-2 RTK.
    Sturk C; Kim H; Jones N; Dumont DJ
    Cell Signal; 2010 Apr; 22(4):676-83. PubMed ID: 20026268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene.
    Dube A; Akbarali Y; Sato TN; Libermann TA; Oettgen P
    Circ Res; 1999 May; 84(10):1177-85. PubMed ID: 10347092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.